Skip to content
AnalystLens
Back to ALNYIncome Statement

ALNYLAM PHARMACEUTICALS, INC. Gross Profit 2017-2025 | ALNY

Annual FY2017–FY2025 · quarterly through Q4 FY2025

Latest annual · FY2025

$3.04B

+56.4%YoY vs FY2024Source: 10-KFY2025

From $89.9M in FY2017 to $3.04B in FY2025: 33.8× in 8 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY25$524M+19.2%$632M+6.6%$1.1B+151.1%$829M+69.1%
FY24$440M+58.3%$593M+143.4%$419M−37.6%$491M+33.4%
FY23$278M+46.4%$243M+27.6%$671M+194.6%$368M+27.3%
FY22$190M+22.8%$191M+0.3%$228M+42.8%$289M+28.4%
FY21$155M+79.3%$190M+122.1%$160M+51.9%$225M+58.6%
Share19%22%29%29%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionGrowing
CAGR

+48.6%

FY2020
$418.7M
FY2025
$3.04B

5 years selected · on the chart

Gross Profit History

Year-over-year comparison from 10-K annual reports

  1. $3.04B
YoY changeLargest recent move+115.0%in FY20Latest +56.4%

1 older move runs past ±150% (largest +17631.1%); point at, tap or drag across the bars to read one.

Gross Profit, period by period

PeriodValueChangeSource
FY2025$3.04B+56.4%10-K
FY2024$1.94B+24.5%10-K
FY2023$1.56B+73.9%10-K
FY2022$897.2M+23.0%10-K
FY2021$729.3M+74.2%10-K
FY2020$418.7M+115.0%10-K
FY2019$194.7M+17631.1%10-K
FY2018$1.1M−98.8%10-K
FY2017$89.9M—10-K

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is ALNYLAM PHARMACEUTICALS, INC.'s current gross profit?

ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual gross profit for 2025 was $3.04B, a 56.40% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. gross profit for the quarter ending December 31, 2025 was $829.3M.

What was ALNYLAM PHARMACEUTICALS, INC.'s gross profit in 2024?

ALNYLAM PHARMACEUTICALS, INC. annual gross profit for 2024 was $1.94B, a 24.46% increase from 2023.

What was ALNYLAM PHARMACEUTICALS, INC.'s gross profit in 2023?

ALNYLAM PHARMACEUTICALS, INC. annual gross profit for 2023 was $1.56B, a 73.87% increase from 2022.

What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year gross profit CAGR?

ALNYLAM PHARMACEUTICALS, INC. gross profit grew at a compound annual growth rate (CAGR) of 48.63% from FY2020 to FY2025, going from $418.7M to $3.04B over 5 years.

Company
ALNYLAM PHARMACEUTICALS, INC.
Ticker
ALNY
Sector
Healthcare
Industry
Pharmaceutical Preparations